Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Lipigem TM
Active ingredients: gemfibrozil
What it is used for
LIPIGEM is indicated as an adjunct to diet and other therapeutic measures for: *Severe hypertriglyceridaemia (Type IV and V) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them. *Dyslipidaemia associated with diabetes. *Reduction of risk of coronary heart disease in patients with Type IIa and IIb hypercholesterolaemia. Because of potential toxicity such as malignancy, gallbladder disease, abdominal pain leading to appendectomy and other abdominal surgeries, an increased incidence in noncoronary mortality, and the 29% increase in all-cause mortality seen with the chemically and pharmacologically related drug, clofibrate, the potential benefits of gemfibrozil in treating Type IIa patients with elevations of LDL-cholesterol only are not likely to outweigh the risks. In a subgroup analysis of patients in the Helsinki Heart Study with above-median HDL-cholesterol values at baseline (greater than 1.2mmol/L), the incidence of serious coronary events was similar for gemfibrozil and placebo subgroups. NOTE: LIPIGEM IS INDICATED WHEN EXERCISE, WEIGHT LOSS AND SPECIFIC DIETARY OR OTHER NONDRUG MEASURES SUCH AS LIMITING ALCOHOL INTAKE HAVE FAILED. OTHER MEDICAL DISORDERS SUCH AS HYPOTHYROIDISM AND DIABETES SHOULD BE CONTROLLED AS MUCH AS POSSIBLE. PERIODIC DETERMINATION OF SERUM LIPIDS SHOULD BE OBTAINED DURING TREATMENT WITH LIPIGEM. THE DRUG SHOULD BE WITHDRAWN OR ADDITIONAL THERAPY INSTITUTED IF THE LIPID RESPONSE IS DEEMED INADEQUATE AFTER THREE MONTHS.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 18 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
19 mm x 9.2 mm deep convex, white, film coated oval shape tablet, debossed,GL600 on one side and Greek alpha symbol on the other.
Images are the copyright of Medicines Information Pty Ltd
We are currently experiencing issues with Medicines Information data. Images displayed may not be current, please refer to the CMI.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on April 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient gemfibrozil
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
